144 related articles for article (PubMed ID: 36290849)
21. Precision Medicine for Heart Failure: Lessons From Oncology.
Feldman AM; Kontos CD; McClung JM; Gerhard GS; Khalili K; Cheung JY
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611130
[No Abstract] [Full Text] [Related]
22. Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One.
Thompson MA; Godden JJ; Wham D; Ruggeri A; Mullane MP; Wilson A; Virani S; Weissman SM; Ramczyk B; Vanderwall P; Weese JL
J Patient Cent Res Rev; 2019; 6(1):36-45. PubMed ID: 31414022
[TBL] [Abstract][Full Text] [Related]
23. [Genetic tumour diagnostics and personalised medicine from a systems perspective].
Schillinger G
Z Evid Fortbild Qual Gesundhwes; 2023 Jun; 179():91-94. PubMed ID: 37183116
[TBL] [Abstract][Full Text] [Related]
24. Digital twins in medicine.
Laubenbacher R; Mehrad B; Shmulevich I; Trayanova N
Nat Comput Sci; 2024 Mar; 4(3):184-191. PubMed ID: 38532133
[TBL] [Abstract][Full Text] [Related]
25. Personalized Medicine in Oncology in the Developing World: Barriers and Concepts to Improve
Adeniji AA; Dulal S; Martin MG
World J Oncol; 2021 Jun; 12(2-3):50-60. PubMed ID: 34046099
[TBL] [Abstract][Full Text] [Related]
26. Application of Smart Infrastructure Systems approach to precision medicine.
Govindaraju DR; Annaswamy AM
Appl Transl Genom; 2015 Dec; 7():40-4. PubMed ID: 27054084
[TBL] [Abstract][Full Text] [Related]
27. The regulatory landscape of precision oncology laboratory medicine in the United States - Perspective on the past 5 years and considerations for future regulation.
Konnick EQ
Pract Lab Med; 2020 Aug; 21():e00172. PubMed ID: 32509953
[TBL] [Abstract][Full Text] [Related]
28. Actionability and precision oncology.
Schwaederle M; Kurzrock R
Oncoscience; 2015; 2(10):779-80. PubMed ID: 26682241
[No Abstract] [Full Text] [Related]
29. Correction to: Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.
Vodicska B; Déri J; Tihanyi D; Várkondi E; Kispéter E; Dóczi R; Lakatos D; Dirner A; Vidermann M; Filotás P; Szalkai-Dénes R; Szegedi I; Bartyik K; Gábor KM; Simon R; Hauser P; Péter G; Kiss C; Garami M; Peták I
World J Pediatr; 2023 May; ():. PubMed ID: 37247168
[No Abstract] [Full Text] [Related]
30. Immunohistochemistry: The Importance of Precision Ontology to Precision Oncology.
Torlakovic EE; Cheung CC
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):61-63. PubMed ID: 38251659
[No Abstract] [Full Text] [Related]
31. Globalization of precision medicine programs in lung cancer: a health system challenge.
Rolfo C; Denninghoff V
Lancet Reg Health Eur; 2024 Jan; 36():100819. PubMed ID: 38170059
[No Abstract] [Full Text] [Related]
32. Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm.
Lajmi N; Alves-Vasconcelos S; Tsiachristas A; Haworth A; Woods K; Crichton C; Noble T; Salih H; Várnai KA; Branford-White H; Orrell L; Osman A; Bradley KM; Bonney L; McGowan DR; Davies J; Prime MS; Hassan AB
Camb Prism Precis Med; 2024; 2():e4. PubMed ID: 38699518
[TBL] [Abstract][Full Text] [Related]
33. Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data.
Hernando-Calvo A; Nguyen P; Bedard PL; Chan KKW; Saleh RR; Weymann D; Yu C; Amir E; Regier DA; Gyawali B; Kain D; Wilson B; Earle CC; Mittmann N; Abdul Razak AR; Isaranuwatchai W; Sabatini P; Spreafico A; Stockley TL; Pugh TJ; Williams C; Siu LL; Hanna TP
EClinicalMedicine; 2024 Mar; 69():102443. PubMed ID: 38380071
[TBL] [Abstract][Full Text] [Related]
34. Ibrutinib Plus RCHOP versus RCHOP Only in Young Patients with Activated B-Cell-like Diffuse Large B-Cell Lymphoma (ABC-DLBCL): A Cost-Effectiveness Analysis.
Rho H; Jeong IJ; Prica A
Curr Oncol; 2023 Dec; 30(12):10488-10500. PubMed ID: 38132398
[TBL] [Abstract][Full Text] [Related]
35. Young Women with Breast Cancer: The Current Role of Precision Oncology.
Srikanthan A; Awan AA; McGee S; Rushton M
J Pers Med; 2023 Nov; 13(11):. PubMed ID: 38003935
[TBL] [Abstract][Full Text] [Related]
36. Precision Medicine for Adolescent and Young Adult (AYA) Oncology.
Srikanthan A
J Pers Med; 2023 Sep; 13(10):. PubMed ID: 37888060
[TBL] [Abstract][Full Text] [Related]
37. Precision Oncology in Canada: Converting Vision to Reality with Lessons from International Programs.
Liu G; Cheung WY; Feilotter H; Manthorne J; Stockley T; Yeung M; Renouf DJ
Curr Oncol; 2022 Sep; 29(10):7257-7271. PubMed ID: 36290849
[TBL] [Abstract][Full Text] [Related]
38. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
39. Challenges and opportunities in building a health economic framework for personalized medicine in oncology.
Aguiar PN; Matsas S; Dienstmann R; Ferreira CG
Per Med; 2023 Sep; 20(5):453-460. PubMed ID: 37602420
[TBL] [Abstract][Full Text] [Related]
40. Real-world data for precision cancer medicine-A European perspective.
Christopoulos P; Schlenk R; Kazdal D; Blasi M; Lennerz J; Shah R; Budczies J; Malek N; Fröhling S; Rosenquist R; Schirmacher P; Bozorgmehr F; Kuon J; Reck M; Thomas M; Stenzinger A
Genes Chromosomes Cancer; 2023 Sep; 62(9):557-563. PubMed ID: 36852573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
